Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea and Vomiting (PONV) at the Upcoming ASPAN 2024 National Conference in Orlando, Florida

17d ago

EGRX

PremiumCompany Announcements

Eagle Pharmaceuticals Risks Nasdaq Delisting Over Filing Delays

20d ago

EGRX

PremiumPress Releases

Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K

20d ago

EGRX

PremiumCompany Announcements

Eagle Pharmaceuticals Announces CFO Transition and Leadership Changes

2M ago

EGRX

PremiumCompany Announcements

Eagle Pharmaceuticals Faces Nasdaq Delisting Deadline

3M ago

EGRX

PremiumMarket News

Eagle Pharmaceuticals Updates Bendamustine IP Portfolio

3M ago

EGRX

PremiumPress Releases

Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio

3M ago

EGRX

More EGRX News >

EGRX News on the Web

2024-04-15

Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea and Vomiting at the Upcoming ASPAN 2024 National Conference in Orlando, Florida

Yahoo Finance

Neutral

2024-03-01

Is Eagle Pharmaceuticals Inc (EGRX) Stock a Smart Value?

Investors Observer

Neutral

2024-02-29

Eagle Pharmaceuticals announces workforce reduction

Investing.com

Bullish

2024-01-23

Eagle Pharmaceuticals Inc (EGRX) Stock Gains 9.62% This Week: Is It a Good Pick?

Investors Observer

Neutral

2024-01-02

SHAREHOLDER ALERT: Potential Recovery for Eagle Pharmaceuticals, Inc. (EGRX) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit

TipRanks News

Bearish

2023-12-19

This 'free lunch' stock trade into year-end has typically netted a 10% return

CNBC

Neutral

2023-12-18

Eagle Pharmaceuticals Inc (EGRX) Stock Falls -10.46% This Week: Is It a Good Pick?

Investors Observer

Neutral

2023-12-08

Eagle Pharmaceuticals faces legal probe over delayed quarterly report, CEO exit

Investing.com

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is EGRX’s Media Buzz Sentiment?

Currently, no data Available

What is EGRX’s weekly average amount of articles?

Currently, no data Available

What is EGRX’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

RMDResmed

OXBDFOxford BioMedica

CNCCentene

NNVCNanoViricides

WGSGeneDx Holdings

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing